"The Covid Vaccine Uptake...Has Collapsed" - NIH Director Jay Bhattacharya

NIH Director Jay Bhattacharya (2024): "The next step is [to halt] the mRNA platform itself... the manufacturer has no idea what dose they're giving, no idea where it goes in the body, and whether the... [injections are]... producing... off-target antigens...."

In this clip from a 2024 Free NZ discussion with former UK MP Andrew Bridgen and Liz Gunn newly confirmed NIH Director Jay Bhattacharya describes three critical flaws with not just the COVID injections, but "the mRNA platform itself." The three critical flaws, Bhattacharya notes, are as follows: "the manufacturer has no idea what...dose they're giving, no idea where it goes in the body, and whether the antigen itself that they're supposedly producing is actually produced, and not... also off-target antigens as well."

Bhattacharya notes that while one Nobel Prize has been awarded for the development of the mRNA platform, at least "two or three more" will be needed before the technology "is ready for primetime."

----------------Partial transcription of clip---------------

"The COVID vaccines themselves, if you look at the actual uptake around the world, certainly in the United States, it's collapsed... I don't think it takes that much more in the in the sense that very, very, very, very few people are still taking these things. And certainly children, the uptake was never very, very high, which is actually really quite a good thing, at least in the United States. So I think that in that sense, the mRNA vaccines for COVID are already, in the minds of the public, in the marketplace, effectively dead. The money that Pfizer is getting from them, the money that Moderna is getting from them, has collapsed from the astronomical levels they got in 2021.

"To me, the next step is the mRNA platform itself. So I've been looking very carefully at the data on that [and]... I'm just telling you what the theory is versus the reality. The theory is that I give you this mRNA code, your cells produce the antigen that I, the scientist, wanted [them] to produce, [and] your immune system reacts to it and then trains it to react to that antigen, which is similar to some of the COVID virus antigen... And that's the theory of the protection. The reality is that the dose of the antigen... that you're induced by one mRNA strand, it could be one, two, three, five [spike proteins]. There's no control over it.

"The dose of the antigen, the dose of the mRNA, you may have some control over, but the dose of the antigen, almost none because you don't have control over how many copies are made of the antigen, per string. The biodistribution of it also is not controllable. So you see evidence of harms in lots of different body systems...[and] one reason might be because the biodistribution of where these antigens are made is not controllable.

"And the third thing is that the fidelity of the proteins made by the code is, for the mRNA technology, not perfect. You often get antigens and proteins that are not in the code itself because they're skipping frame[s]... and other things. And so from a regulatory perspective, how as a regulator do you say, Okay, you can give this product to people even though you don't know the dose that you're giving to people, even though you don't know where it's going in the body, and even though you don't know that you're producing the target antigen that you wanna produce.

"There was a Nobel Prize awarded for the mRNA technology to begin with that allowed it so that it would actually produce the antigens without your body sort of overreacting with this immune overreaction and destroying it or just getting rid of it. [But] there's going to need to be two or three more Nobel Prize winning advances before this is ready for primetime, I think. So that's the next step, is making sure that regulators understand that when they approve products with this mRNA platform, they're approving platforms where the manufacturer has no idea what the dose they're giving, no idea where it goes in the body, and whether the antigen itself that they're supposedly producing is actually produced, and... also not off-target antigens as well."

Thanks to 'Sense Receptor' on X for the clip - https://x.com/SenseReceptor/status/1904921314474762389

Full Interview link - https://rumble.com/v59emm4-dr-jay-bhattacharya-and-andrew-bridgen-freenz.html?e9s=src_v1_ucp